Literature DB >> 21509508

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

M Obulesu1, R Venu, R Somashekhar.   

Abstract

Extracellular accumulations of Aβ, hyperphosphorylation of tau and intracellular neurofibrillary tangle formation have been the hallmarks of Alzheimer's Disease (AD). Although tau and its phosphorylation play a pivotal role in the normal physiology yet its hyperphosphorylation has been a pathological manifestation in neurodegenerative disorders like AD. In this review physiology of tau, its phosphorylation, hyperphosphorylation with the intervention of various kinases, aggregation and formation of paired helical filaments has been discussed. A brief account of various animal models employed to study the pathological manifestation of tau in AD and therapeutic strategies streamlined to counter the tau induced pathology has been given. The reasons for the failure to have suitable animal model to study AD pathology and recent success in achieving this has been included. The role of caspase cascade in tau cleavage has been emphasized. The summary of current studies on tau and the need for future studies has been accentuated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509508     DOI: 10.1007/s11064-011-0475-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  76 in total

Review 1.  Calcium homeostasis and modulation of synaptic plasticity in the aged brain.

Authors:  Thomas C Foster
Journal:  Aging Cell       Date:  2007-06       Impact factor: 9.304

2.  M1 receptors play a central role in modulating AD-like pathology in transgenic mice.

Authors:  Antonella Caccamo; Salvatore Oddo; Lauren M Billings; Kim N Green; Hilda Martinez-Coria; Abraham Fisher; Frank M LaFerla
Journal:  Neuron       Date:  2006-03-02       Impact factor: 17.173

3.  Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.

Authors:  Karin Boekhoorn; Dick Terwel; Barbara Biemans; Peter Borghgraef; Olof Wiegert; Ger J A Ramakers; Koos de Vos; Harm Krugers; Takami Tomiyama; Hiroshi Mori; Marian Joels; Fred van Leuven; Paul J Lucassen
Journal:  J Neurosci       Date:  2006-03-29       Impact factor: 6.167

4.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

5.  A caspase cleaved form of tau is preferentially degraded through the autophagy pathway.

Authors:  Philip J Dolan; Gail V W Johnson
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

6.  Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.

Authors:  Angela L Guillozet-Bongaarts; Michael E Cahill; Vincent L Cryns; Matthew R Reynolds; Robert W Berry; Lester I Binder
Journal:  J Neurochem       Date:  2006-04-05       Impact factor: 5.372

Review 7.  Tau phosphorylation and assembly.

Authors:  Alberto Gómez-Ramos; Mark A Smith; George Perry; Jesús Avila
Journal:  Acta Neurobiol Exp (Wars)       Date:  2004       Impact factor: 1.579

8.  Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.

Authors:  Fei Liu; Jianhua Shi; Hitoshi Tanimukai; Jinhua Gu; Jianlan Gu; Inge Grundke-Iqbal; Khalid Iqbal; Cheng-Xin Gong
Journal:  Brain       Date:  2009-05-18       Impact factor: 13.501

9.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Authors:  M Goedert; M G Spillantini; M C Potier; J Ulrich; R A Crowther
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  19 in total

Review 1.  Need for a paradigm shift in therapeutic approaches to CNS injury.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2012-04       Impact factor: 4.618

Review 2.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

Authors:  Lucas T Woods; Deepa Ajit; Jean M Camden; Laurie Erb; Gary A Weisman
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

Review 3.  Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues.

Authors:  M Obulesu; M Jhansi Lakshmi
Journal:  Neurochem Res       Date:  2014-10-17       Impact factor: 3.996

4.  Can zebrafish be used as animal model to study Alzheimer's disease?

Authors:  Soraya Santana; Eduardo P Rico; Javier S Burgos
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

Review 5.  P2Y receptors in Alzheimer's disease.

Authors:  Laurie Erb; Chen Cao; Deepa Ajit; Gary A Weisman
Journal:  Biol Cell       Date:  2014-10-13       Impact factor: 4.458

6.  Up-regulation and activation of the P2Y(2) nucleotide receptor mediate neurite extension in IL-1β-treated mouse primary cortical neurons.

Authors:  Troy S Peterson; Christina N Thebeau; Deepa Ajit; Jean M Camden; Lucas T Woods; W Gibson Wood; Michael J Petris; Grace Y Sun; Laurie Erb; Gary A Weisman
Journal:  J Neurochem       Date:  2013-04-25       Impact factor: 5.372

7.  Aftins increase amyloid-β42, lower amyloid-β38, and do not alter amyloid-β40 extracellular production in vitro: toward a chemical model of Alzheimer's disease?

Authors:  Arnaud Hochard; Nassima Oumata; Karima Bettayeb; Olfa Gloulou; Xavier Fant; Emilie Durieu; Nelly Buron; Mathieu Porceddu; Annie Borgne-Sanchez; Hervé Galons; Marc Flajolet; Laurent Meijer
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Differential expression of proteins in brain regions of Alzheimer's disease patients.

Authors:  Saadia Zahid; Michael Oellerich; Abdul R Asif; Nikhat Ahmed
Journal:  Neurochem Res       Date:  2013-12-04       Impact factor: 3.996

9.  Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus.

Authors:  Filipa I Baptista; Maria J Pinto; Filipe Elvas; Ramiro D Almeida; António F Ambrósio
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

10.  Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.

Authors:  Niloufar Ansari; Fariba Khodagholi
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.